Regulatory News
Monday, May 2, 2016
BRIEF-Orexigen therapeutics wins South Korean approval for Contrave
* Has shipped an initial order of contrave tablets to kwang
dong pharmaceutical company, ltd.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment